The Journal of Experimental Medicine
Avanti Polar Lipids, Inc.
  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents

Published online
doi:10.1084/jem.20091059
The Journal of Experimental Medicine, Vol. 206, No. 9, 1863-1871
The Rockefeller University Press, 0022-1007 $30.00
© Kaiser et al.
This Article
Right arrow Full Text
Right arrow Full Text (PDF, 2308K)
Right arrow PDF+supp data (2744K)
Right arrow PPT slides of all figures
Right arrow Supplemental Material
Right arrow Alert me when this article is cited
Right arrow Citation Map
Services
Right arrow Email this article
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new content in the JEM
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via CrossRef
Google Scholar
Right arrow Articles by Kaiser, F.
Right arrow Articles by O'Garra, A.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kaiser, F.
Right arrow Articles by O'Garra, A.
Right arrowPubmed/NCBI databases
*Gene*GEO Profiles
*HomoloGene*Protein
*UniGene
*Substance via MeSH
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

BRIEF DEFINITIVE REPORT

TPL-2 negatively regulates interferon-β production in macrophages and myeloid dendritic cells

Frank Kaiser1, Dorthe Cook1,2, Stamatia Papoutsopoulou2, Ricardo Rajsbaum1, Xuemei Wu1, Huei-Ting Yang2, Susan Grant2, Paola Ricciardi-Castagnoli3, Philip N. Tsichlis4, Steven C. Ley2, and Anne O'Garra1

1 Division of Immunoregulation and 2 Division of Immune Cell Biology, Medical Research Council National Institute for Medical Research, Mill Hill, London NW7 1AA, UK
3 Singapore Immunology Network, Biopolis, SINGAPORE 138648
4 Molecular Oncology Research Institute, Tufts-New England Medical Center, Boston, MA 02111

CORRESPONDENCE Anne O'Garra: aogarra{at}nimr.mrc.ac.uk OR Steven C. Ley: sley{at}nimr.mrc.ac.uk

Stimulation of Toll-like receptors (TLRs) on macrophages and dendritic cells (DCs) by pathogen-derived products induces the production of cytokines, which play an important role in immune responses. Here, we investigated the role of the TPL-2 signaling pathway in TLR induction of interferon-β (IFN-β) and interleukin-10 (IL-10) in these cell types. It has previously been suggested that IFN-β and IL-10 are coordinately regulated after TLR stimulation. However, in the absence of TPL-2 signaling, lipopolysaccharide (TLR4) and CpG (TLR9) stimulation resulted in increased production of IFN-β while decreasing IL-10 production by both macrophages and myeloid DCs. In contrast, CpG induction of both IFN-{alpha} and IFN-β by plasmacytoid DCs was decreased in the absence of TPL-2, although extracellular signal-regulated kinase (ERK) activation was blocked. Extracellular signal-related kinase–dependent negative regulation of IFN-β in macrophages was IL-10–independent, required protein synthesis, and was recapitulated in TPL-2–deficient myeloid DCs by retroviral transduction of the ERK-dependent transcription factor c-fos.


F. Kaiser, D. Cook, S. Papoutsopoulou, and R. Rajsbaum contributed equally to this paper.

Abbreviations used: BMDC, BM-derived DC; BMDM, BM-derived macrophage; CHX, cycloheximide; ERK, extracellular signal-regulated kinase; IKK, I{kappa}B kinase; IRF, IFN regulatory factor; JNK, Jun N-terminal kinase; MAPK, mitogen-activated protein kinase; MAPKKK, MAP-3 kinase; pDC, plasmacytoid DC; TIR, Toll/IL-1R; TLR, Toll-like receptor; TRAF, TNF receptor-associated factor; TRIF, TIR domain–containing adaptor inducing IFN-β.

© 2009 Kaiser et al.
This article is distributed under the terms of an Attribution–Noncommercial–Share Alike–No Mirror Sites license for the first six months after the publication date (see http://www.jem.org/misc/terms.shtml). After six months it is available under a Creative Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license, as described at http://creativecommons.org/licenses/by-nc-sa/3.0/).


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?




  Home | Help | Feedback | Subscriptions | Archive | Search
TABLE OF CONTENTS